Bayern Kapital
Wholly owned venture capital subsidiary of the Bavarian state development bank LfA Förderbank Bayern
Also known as Bayern Kapital GmbH
Landshut-based venture capital subsidiary of LfA Förderbank Bayern; about €1.3bn under management, €250k–€50M tickets in Bavarian tech startups and scaleups.
Not to be confused with BayBG Bayerische Beteiligungsgesellschaft (Munich), the separate Bavarian MBG that often co-invests as a private mirror partner.
- HEADQUARTERS
- Landshut, Germany
- FOUNDED
- 1995
- AUM
- €1.3B (2026)
- OUTSIDE CAPITAL
- —
- TEAM LISTED
- 38 people
Focus
- STAGES
- Pre-SeedSeedSeries ASeries BGrowth
- SECTORS
- Deep TechSoftware & SaaSBiotech & Life SciencesHealthTechClimate & EnergyIndustrial & ManufacturingSpaceArtificial Intelligence
- ASSET MIX
- Venture capitalDirect investments
- GEOGRAPHY
- Germany
Investment arms & vehicles
- Seed fund for young Bavarian tech companies up to 24 months old; tickets up to €750k
- Early-stage fund for Bavarian tech companies from founding; tickets up to €2.5M (up to €8M with EU STEP money)
- EFRE-funded early-stage fund for tech companies in Bavaria's EFRE regions; tickets up to €3M
- Growth fund for companies after a Series A, mostly alongside private investors; tickets €2–10M
- €200M fund for capital-intensive, fast-growing tech companies; tickets €10–25M
- €500M later-stage fund, the largest and newest; tickets up to €50M
Overview
Bayern Kapital GmbH has been the venture capital investor of the Free State of Bavaria since 1995 and is a wholly owned subsidiary of LfA Förderbank Bayern, based in Landshut. It manages about €1.3bn across several funds, from the Seedfonds Bayern to the €500M Wachstums- und ScaleUp-Fonds, and says it has financed more than 380 Bavarian high-tech startups, with about 120 active portfolio companies. It always invests as a co-investor alongside private investors on pari-passu terms, as a minority shareholder, with holding periods of usually five to ten years.
Investment thesis
Bavarian high-tech and deep-tech startups and scaleups with scalable product businesses (biotech and life sciences, medtech, software and IT, environmental and nanotechnology, materials), from pre-seed to growth and exit, always alongside private co-investors.
PORTFOLIO (161)
- 36ZEROVision
- 4screen
- abaut GmbH
- adnymics GmbHExited
- ADVANOVA GmbH
- Akhetonics
- AlfaDocs
- All3DP
- AltrujaExited
- Amplifold
- AMWExited
- apaleo
- AppNavi
- Aves
- Bilendo GmbH
- Böhner-EH GmbHExited
- BOX ID Systems
- Caire
- casavi
- CatalYm
- Cevotec GmbHExited
- ChargeX
- ChromoTekExited
- Cliniserve
- Cobrainer
- commercetoolsExited
- Conntac
- Constellr
- COREDINATEExited
- CorimmunExited
- CPTx
- Crealytics
- Cunesoft GmbHExited
- DeepDrive
- deepeye Medical
- Delicious Data
- DRIMCO GmbH
- driveblocks
- Dynamic BiosensorsExited
- Easy-Tutor
- Ebenbuild
- EcoG
- EGYM
- eKidz.eu
- emax digital
- encosa
- Enmacc
- EOSExited
- Erium
- Ewigbyte
- ExB Labs
- Exergy3
- ExoMatter
- EXTEND3DExited
- EyeSense GmbHExited
- famPLUS
- FazuaExited
- Filics
- Flowsight
- fos4XExited
- FTAPIExited
- Gastfreund
- GeneArt AGExited
- GME German Medical EngineeringExited
- GNA BiosolutionsExited
- hema.to
- HiveMQ
- Hololight
- iATROSExited
- Immunic Therapeutics
- inContAlert
- Insempra
- IQM Quantum Computers
- Isar Aerospace
- knowis AG
- leadtributor
- Limata
- LUMA Vision
- Maple Aviation GmbH
- Marvel Fusion
- mbiomics
- MC Sciences
- Medineering GmbHExited
- memtime
- MetodaExited
- MicrometExited
- MorphosysExited
- multimmune
- Multiphoton OpticsExited
- munevo
- Munich Quantum Instruments
- Nanda TechnologiesExited
- NanoStruct
- Nature Robots
- NeoPredics AG
- Neuramancer AI
- Noxon
- NUCLIDIUM AG
- Numares HEALTH
- OCELL
- oculai
- ondesoExited
- OroraTech
- parcelLabExited
- PartSpace
- Pelicad
- Photonics HealthcareExited
- Picture Framing GmbH (Mozaik)
- Planet A Foods
- Planqc
- PlixosExited
- ProGloveExited
- PropertybaseExited
- Proxima Fusion
- Pulsetrain
- QbilonExited
- Quantum Systems
- QuantumDiamonds GmbH
- Reflex Aerospace
- reINVENTExited
- riskmethodsExited
- RyteExited
- SciRhom
- Scompler Technologies
- Secfix
- sewts
- SimScale
- SIRION BiotechExited
- Smart Reporting
- SmartAIs
- smartbax
- SPiNE
- StrategyBridgeAI
- Sunhill technologies GmbHExited
- SuppreMol GmbHExited
- Symphera
- T-Curx
- tado°
- The Electric Car Scheme
- The Exploration Company
- Thermosome GmbH
- THEVA Dünnschichttechnik GmbHExited
- Tidely GmbH
- tiramizooExited
- TM3Exited
- TNI MedicalExited
- traplinked GmbH
- TRiCares
- TubulisExited
- Twogee Biotech
- ubiMaster
- VanatecExited
- Vantis
- VEACTExited
- Vectoflow
- virtonomy.io
- VITAS
- workerbase
- WorkerHero
- XO Life
- SubraClimate & Energy · since 2026
People
- Monika StegerManaging Director · source
- Markus MrachaczManaging Director · source
- Dr. Sabine JarotheChair of the Supervisory Board · source
- Bernd SchafbergerHead of Venture Capital Investments, Prokurist · source
- Bernhard KöhlerInvestment Director and Prokurist · source
- Ariel GolanInvestment Director · source
- Benjamin SchwiewagnerInvestment Director · source
- Dr. Nathalie WeitemeyerDirector Life Science and Senior Investment Manager · source
- Klaus LöschnerTeam Lead and Prokurist · source
- Madeleine GuggenheimHead of Marketing, Communications & Relations · source
- Martin RedlInvestment Director · source
- Simon KreitmairInvestment Director · source
- Stefan EnglHead of Finance and Administration, Prokurist · source
- Thomas HutterChief Risk Officer and Prokurist · source
- Wolfgang DenglerHead of Venture Capital Investments, Prokurist · source
- Wolfgang HärtlInvestment Director · source
- Andreas HuberSenior Investment Manager · source
- Brigitte LinseisSenior Investment Manager · source
- Ahmet BayramInvestment Manager · source
- Bettina GrotzInvestment Manager · source
- Christoph WirthSenior Investment Manager · source
- Franz SalzerSenior Investment Manager · source
- Franz WocheslanderSenior Investment Manager · source
- Dominik NeumüllerInvestor Relations Manager · source
- Florian EbelInvestment Manager · source
- Florian ZeidlerInvestment Manager · source
- Lisa LiuSenior Investment Manager · source
- Franziska PfeifferInvestment Manager · source
- Katerina StraubHead of Controlling · source
- Markus PorschInvestment Manager · source
- Mathias MatusekInvestment Manager · source
- Matthias BuchingerInvestment Manager · source
- Matthias WolfInvestment Manager · source
- Regina GraßlSenior Investment Manager · source
- Thomas ManittaSenior Investment Manager · source
- Sarah GscheiderInvestment Manager · source
- Stefan AumerInvestment Manager · source
- Dr. Vanessa LuzakInvestment Manager · source
Links
Frequently asked questions
Bayern Kapital is a government-backed fund based in Landshut, Germany, founded in 1995.
Yes. Bayern Kapital invests its own capital in private companies.
Bayern Kapital invests at Pre-Seed, Seed, Series A, Series B and Growth stages in Deep Tech, Software & SaaS, Biotech & Life Sciences, HealthTech, Climate & Energy, Industrial & Manufacturing, Space and Artificial Intelligence.
Bayern Kapital's stated ticket size is €250K–€50M.
Key people at Bayern Kapital include Monika Steger (Managing Director), Markus Mrachacz (Managing Director), Dr. Sabine Jarothe (Chair of the Supervisory Board) and Bernd Schafberger (Head of Venture Capital Investments, Prokurist).
Bayern Kapital's investments include 36ZEROVision, 4screen, abaut GmbH, adnymics GmbH, ADVANOVA GmbH, Akhetonics, AlfaDocs and All3DP, among others.
The most recent publicly reported investment by Bayern Kapital is Subra, announced in Jul 2026.
Bayern Kapital states that it accepts submissions through its official contact page.